Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth
Eurofins Makes Significant Progress in H1 2026 Towards Its Mid-Term 2027 Objectives, With 130bps of Adjusted EBITDA Margin Expansion, Strong Cash Conversion, and 29% EPS Growth
Regulatory News:
Eurofins (Paris:ERF):
Financial highlights in H1 2026
Basic EPS8 grew 29% to €1.55 in H1 2026 vs €1.20 in H1 2025, as Eurofins continued to accumulate the operational benefits from the five-year investment programme in its hub and spoke network of laboratories and digitalisation initiatives.
Eurofins: Weekly Report on Share Repurchases From 01st June to 05th June 2026
Eurofins Scientific SE: Weekly report on share repurchases from 29th June to 03rd July 2026
Eurofins Scientific SE: Weekly Report on Share Repurchases from 08th June to 12th June 2026
Eurofins Scientific SE: Weekly Report on Share Repurchases From 25th May to 29th May 2026
Eurofins Scientific SE: Weekly Report on Share Repurchases from 13th July to 17th July 2026
Eurofins Scientific SE: Weekly Report on Share Repurchases From 06th July to 10th July 2026
